Andy Obermueller
Government-Driven Investing
Keith Fitz-Gerald
New China Trader
Marvin Appel
Systems & Forecasts
Jim Powell
Global Changes & Opportunities Report

China Medical (CMED): Diagnostic gains


Bookmark and Share

 China Medical Technologies (NASDAQ: CMED), a maker of medical diagnostics equipment, is a buy from Asia stock expert Jim Trippon in his The China Stock Digest.

"The stock has rebounded strongly after a difficult summer -- partly because of news about the firm’s share buyback program and because of its earnings report.

"In September, the CMED board authorized the company to repurchase up to $30 million worth of its outstanding American Depositary Shares for a period of one year, commencing on October 1, 2009.

Advertisement
Banner

"Meanwhile, CMED reported its financial results for the fourth fiscal quarter and fiscal year ended March 31, 2009 and the first fiscal quarter ended June 30, 2009 on September 1.

"The company reported revenues from continuing operations of $36.4 million for 4Q 2008, representing a 37.3% increase from the corresponding period of 2007.

"Its revenues from continuing operations are currently generated from two product lines, ECLIA diagnostic systems and FISH diagnostic systems.

"ECLIA system sales for the fourth quarter of 2008 were $20.3 million, representing a 23.9% increase from the corresponding period of 2007. The year-over-year growth in the ECLIA system sales was primarily due to the increasing utilization of CMED’s ECLIA analyzers by hospitals.

"FISH system sales for the fourth quarter of 2008 were $16.0 million, representing a 59.3% increase from the corresponding period of 2007. Gross margin increased to 75.8% for 4Q 2008 from 58.6% for the corresponding period of 2007. 

"Revenues for the full fiscal year of 2008 from continuing operations were $121.5 million, representing a 51.6% year-over-year increase.

"These are very encouraging numbers and support our confidence in this growing diagnostic medical device firm. CMED is still a buy, selling below its buy-up-to price of $22 a share."




News Flash

Geron (GERN)
Steve Christ, The Wealth Advisory

In a recent 15-page ruling, a U.S. judge ruled that using taxpayer dollars to fund embryonic stem cell research violates a 1996 law; but in the case of Geron Corp. (GERN), the company won’t be affected at all.


Read more...

 

Industrial trio: BWA, TEN, DXPE
Stephen Quickel, US Investment Report

Among our new stock are three industrials that expected to grow earnings by 30% a year: Borg Warner (BWA), Tenneco (TEN) and DXP Enterprises (DXPE).


Read more...


Banner
Banner
   

Bullion Monarch Mining (BULM)
Max Bowser, The Bowser Report

Bullion Monarch Mining (BULM) -- a holding in our "penny stock" portfolio -- recorded its best revenue year ever.


Read more...

 

Global X Lithium ETF (LIT)
Jim Trippon, ETF Profit Report

It’s rare that we would recommend an ETF that is as new as Global X Lithium (LIT), but with the market taking a tumble, we believe we’re getting good value on this newly-minted vehicle.


Read more...

 

Consumer Staples (XLP)
by Doug Fabian, Making Money Alert

The Consumer Staples Select Sector SPDR (XLP) is an ETF that tracks companies that have products that people need in both good and bad economic times.


Read more...

 

WisdomTree SmallCap Dividend (DES)
by Walter Frank, MoneyLetter

WisdomTree SmallCap Dividend (DES), which sports an attractive 4.3% yield, has been added to our fund coverage.


Read more...

 

Closed-end income favorites
by Harry Domash, Dividend Detective

The latest new positions in our closed-end fund portfolio are Guggenheim Emerging Opportunity (GOF) and First Trust/Aberdeen Emerging Opportunity (FEO).


Read more...

 

Quality trio: XOM, GOOG, JNJ
by Adam Sharp, contributing editor Wealth Daily

Buying defensive blue chips makes sense. Three of my favorites are ExxonMobil (XOM), Johnson and Johnson (JNJ) and Google (GOOG).


Read more...

 

Xcel Energy (XEL)
by Roger Conrad, The Utility Forecaster

In late 2002 Xcel Energy (XEL) was on the brink of Chapter 11; it has since come back, recently earning a credit upgrade from S&P to A- with an "excellent" risk profile.


Read more...

 

Virginia Mines (VGQ)
by Adrian Day, The Global Analyst

Virginia Mines (VGQ) remains one of a handful of my favorite companies; the company continues ongoing rationalization of its extensive mining property portfolio.


Read more...